Research Associate, Department of Veterinary and Biomedical Sciences
University of Minnesota, USA
Vikram Verma's research interest focus on development of vaccines and therapeutic measures for infectious diseases. He developed Pichinde virus (PICV) as a vaccine vector platform and showed its efficacy against influenza virus infection through recombinant PICV virus expressing influenza genes. His other research interest involves identifying the novel host factors that are important for the replication and pathogenesis of Influenza viruses and could be targeted by antiviral drugs. He identified TrkA (a receptor tyrosine kinase) as a promising candidate target and demonstrated therapeutic potential of TrkA inhibitors in both in-vitro cell culture and in vivo mouse models.